Detalhe da pesquisa
1.
An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.
Mol Ther
; 26(2): 379-389, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174843
2.
Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.
J Immunol
; 190(12): 6034-42, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690473
3.
An antigenic peptide produced by reverse splicing and double asparagine deamidation.
Proc Natl Acad Sci U S A
; 108(29): E323-31, 2011 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670269
4.
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic Melanoma.
Clin Cancer Res
; 28(14): 3042-3052, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247926
5.
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.
J Clin Oncol
; 40(16): 1741-1754, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104158
6.
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
Science
; 375(6583): 877-884, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113651
7.
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.
Cancer Immunol Res
; 10(8): 932-946, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749374
8.
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types.
Nat Cancer
; 2(5): 563-574, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927080
9.
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.
Science
; 370(6522): 1328-1334, 2020 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303615
10.
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.
Cancer Res
; 67(8): 3898-903, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17440104
11.
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.
Cancer Discov
; 9(8): 1022-1035, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164343
12.
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
J Clin Oncol
; 35(29): 3322-3329, 2017 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28809608
13.
Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes.
Cancer Res
; 63(20): 6735-43, 2003 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583468
14.
Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.
Cancer Res
; 62(18): 5144-7, 2002 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12234976
15.
Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.
J Immunother
; 39(5): 191-201, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27163739
16.
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.
Cancer Immunol Res
; 4(8): 669-78, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27312342
17.
Immunogenicity of somatic mutations in human gastrointestinal cancers.
Science
; 350(6266): 1387-90, 2015 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516200
18.
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
J Clin Invest
; 125(10): 3981-91, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26389673
19.
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Clin Cancer Res
; 21(5): 1019-27, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25538264
20.
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.
J Clin Oncol
; 33(6): 540-9, 2015 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25154820